Prostate Cancer

miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer. September 21, 2020

Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. September 21, 2020

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-Resistant Prostate Cancer: A Phase 1 Study of Concurrent Enzalutamide and Crizotinib. September 21, 2020

Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance. September 21, 2020

Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC. September 21, 2020

USC Urology Experts Share Valuable Insight During Prostate Cancer Awareness Month September 18, 2020

Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades. September 18, 2020

Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells. September 18, 2020

Acceptance, Indications And Chances Of Focal Therapy In Localized Prostate Cancer: A Real-World Perspective Of Urologists In Germany. September 18, 2020

Targeting the BAF complex in advanced prostate cancer. September 18, 2020

Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review. September 18, 2020

Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study. September 17, 2020

Can postreatment free psa ratio be used to predict adverse outcomes in recurrent prostate cancer? September 17, 2020

Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer. September 17, 2020

Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer. September 17, 2020

Diagnostic yields in patients with suspected prostate cancer undergoing MRI as the first-line investigation in routine practice. September 17, 2020

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study. September 16, 2020

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. September 16, 2020

Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer. September 16, 2020

Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer. September 16, 2020

Page 1 of 1103